|
|
Market Analysis Reports of Bupivacaine
|
BUPIVACAINE BASE (CAS 2180-92-9) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
Bupivacaine hydrochloride monohydrate (CAS 14252-80-3) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
Bupivacaine hydrochloride (CAS 18010-40-7) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
(±)-Bupivacaine-d9 (butyl-d9) (CAS 474668-57-0) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
Bupivacaine hydrochloride Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
Levobupivacaine Hydrochloride(DMF) (CAS 14252-80-3) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
Levobupivacaine hydrochloride (CAS 27262-48-2) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
BUSULFAN (CAS 55-98-1) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
Global Market Report of Bupivacaine (CAS 2180-92-9) December 2024
Durect Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... POSIDUR, a sustained-release formulation of bupivacaine, using its SABER delivery ... : The company is developing a transdermal bupivacaine patch (ELADUR) based on its ... technology intended to provide continuous delivery of bupivacaine for up to three days from ...
Pacira BioSciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... . Its lead product candidate is EXPAREL (bupivacaine liposome injectable suspension), which consists ... of bupivacaine, an amide-type local anesthetic, encapsulated in ...
Global Market Report of (R)-(+)-BUPIVACAINE HCL (CAS 27262-45-9) December 2024
Global Market Report of (R)-(+)-Bupivacaine monohydrochloride (CAS 27262-46-0) December 2024
Global Market Report of bupivacaine hydrochloride (CAS 18010-40-7) December 2024
Global Market Report of Bupivacaine hydrochloride (CAS 14252-80-3) December 2024
Global Market Report of bupivacaine hydrochloride (CAS 18010-40-7) December 2024
EpiCept Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... property for a transdermal patch containing bupivacaine for the treatment of back pain ...
Aratana Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... (AT-003 for dogs, also known as bupivacaine liposome injectable suspension for dogs ...
Global Bupivacaine Liposome Injectable Suspension Market Growth 2024-2030 ... potential of the global Bupivacaine Liposome Injectable Suspension market. Bupivacaine Liposome Injectable Suspension ... . This include advancements in Bupivacaine Liposome Injectable Suspension technology, Bupivacaine Liposome Injectable Suspension ...
Global Liposomal Bupivacaine Market Growth 2024-2030 ... opportunities presented by the Liposomal Bupivacaine market. Liposomal bupivacaine has been approved by the ... Bupivacaine industry. This include advancements in Liposomal Bupivacaine technology, Liposomal Bupivacaine new entrants, Liposomal Bupivacaine ...
|
|
|
|